Nathan Haselton

Nathan advises clients on commercial strategy engagements including portfolio strategy, licensing and M&A advisory, brand & launch strategy, and opportunity assessments.

His recent experience includes hematological malignancies, solid tumors, vaccines, autoimmune conditions, CNS disorders, and metabolic disorders. Nathan has worked with a broad range of clients including top 10 pharmaceutical companies, early stage biotechs, and financial sponsors. Prior to joining Putnam, Nathan was a project leader at IQVIA Consulting Services, and has worked in healthcare private equity and investment banking in the US and Europe. He received his B.A. from Johns Hopkins University and worked on novel drug development concurrent to his education resulting in several publications.